A randomized, open‐label, phase 2, multicenter trial of gemcitabine with pazopanib or gemcitabine with docetaxel in patients with advanced soft‐tissue sarcoma

Cancer ◽  
2020 ◽  
Author(s):  
Neeta Somaiah ◽  
Brian Andrew Van Tine ◽  
Amy E. Wahlquist ◽  
Mohammed M. Milhem ◽  
Elizabeth G. Hill ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Multicenter Trial ◽  
Phase 2 ◽  
Open Label ◽  
Advanced Soft Tissue Sarcoma ◽  
Open Label Phase

scholarly journals Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

2017 ◽  
Vol 18 (11) ◽  
pp. 1493-1501 ◽  
Author(s):  
Hussein A Tawbi ◽  
Melissa Burgess ◽  
Vanessa Bolejack ◽  
Brian A Van Tine ◽  
Scott M Schuetze ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Bone Sarcoma ◽  
Phase 2 ◽  
Open Label ◽  
Advanced Soft Tissue Sarcoma ◽  
Phase 2 Trial ◽  
Open Label Phase

scholarly journals Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial

2013 ◽  
Vol 14 (4) ◽  
pp. 371-382 ◽  
Author(s):  
Gary K Schwartz ◽  
William D Tap ◽  
Li-Xuan Qin ◽  
Michael B Livingston ◽  
Samir D Undevia ◽  
...  
Keyword(s):  
Soft Tissue ◽  
Soft Tissue Sarcoma ◽  
Phase 2 ◽  
Open Label ◽  
Phase 2 Trial ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document